Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma
Clinical trial NCT03088176 · UNKNOWN
Trial details
- NCT number
- NCT03088176
- Sponsor
- West Cancer Center
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-25
- Primary completion
- 2020-11-30
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.